about
Posttransplant recurrence of atypical hemolytic uremic syndrome.Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations.A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation.Dynamics of complement activation in aHUS and how to monitor eculizumab therapyMapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome.Characterization of a New DGKE Intronic Mutation in Genetically Unsolved Cases of Familial Atypical Hemolytic Uremic SyndromeComplement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome.Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.Association of CFHR1 homozygous deletion with acute myelogenous leukemia in the European population.
P50
Q33402141-00EDAE9E-0CBC-4C02-99A7-78D36B844533Q33406025-D6967F39-CD5B-40FF-8C64-337DC24F7250Q33408171-16D30A1C-840C-4B68-8E3F-C720ED944F59Q33415753-C2C4F417-252F-4426-A2E1-34AE02E7031AQ33416519-19B81F52-4B5A-444E-88F1-2E9B6A5FEBF2Q33419905-40087C7F-EB49-4673-867C-CFDAA3B44EA4Q33421800-FE3FE965-4590-4FD3-9736-ACF58C67D087Q39983750-B6729380-E8FB-47E7-9D37-505DF8BF2B72Q47650832-AD9E0D5D-3656-454B-85FC-D148BC1AD9CDQ50854174-FE19DD27-225E-4912-BD68-9B5D94BF9282
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Elisabetta Valoti
@ast
Elisabetta Valoti
@en
Elisabetta Valoti
@es
Elisabetta Valoti
@nl
type
label
Elisabetta Valoti
@ast
Elisabetta Valoti
@en
Elisabetta Valoti
@es
Elisabetta Valoti
@nl
prefLabel
Elisabetta Valoti
@ast
Elisabetta Valoti
@en
Elisabetta Valoti
@es
Elisabetta Valoti
@nl
P106
P31
P496
0000-0002-9997-3800